Literature DB >> 16511043

Crystallization and preliminary X-ray diffraction of the ZO-binding domain of human occludin.

Bi Hung Peng1, Mark A White, Gerald A Campbell, Jebamony J Robert, J Ching Lee, Roger B Sutton.   

Abstract

Occludin is a tight-junction protein controlling the integrity of endothelial and epithelial cell layers. It forms complexes with the cytoplasmic proteins ZO-1, ZO-2 and ZO-3. The ZO-binding domain in the C-terminal cytoplasmic region of human occludin has previously been isolated and identified. This domain, as expressed in a bacterial system or isolated from native cellular occludin, maintains its ability to bind ZO-1 and ZO-2. The crystallization conditions of the human ZO-binding domain are reported here. The crystals diffract to 2.3 A resolution and were shown to belong to the orthorhombic space group P2(1)2(1)2(1), with unit-cell parameters a = 33.3, b = 35.4, c = 107.3 A.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16511043      PMCID: PMC1952431          DOI: 10.1107/S1744309105007475

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  17 in total

1.  Protein interactions at the tight junction. Actin has multiple binding partners, and ZO-1 forms independent complexes with ZO-2 and ZO-3.

Authors:  E S Wittchen; J Haskins; B R Stevenson
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

2.  The CCP4 suite: programs for protein crystallography.

Authors: 
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-09-01

3.  Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis.

Authors:  L M Dallasta; L A Pisarov; J E Esplen; J V Werley; A V Moses; J A Nelson; C L Achim
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

4.  Processing of X-ray diffraction data collected in oscillation mode.

Authors:  Z Otwinowski; W Minor
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

5.  Blood-brain barrier damage in patients with bacterial meningitis: association with tumor necrosis factor-alpha but not interleukin-1 beta.

Authors:  M K Sharief; M Ciardi; E J Thompson
Journal:  J Infect Dis       Date:  1992-08       Impact factor: 5.226

6.  A comparison of salts for the crystallization of macromolecules.

Authors:  A McPherson
Journal:  Protein Sci       Date:  2001-02       Impact factor: 6.725

7.  Characterization of ZO-2 as a MAGUK family member associated with tight as well as adherens junctions with a binding affinity to occludin and alpha catenin.

Authors:  M Itoh; K Morita; S Tsukita
Journal:  J Biol Chem       Date:  1999-02-26       Impact factor: 5.157

8.  In vitro protein complex formation with cytoskeleton-anchoring domain of occludin identified by limited proteolysis.

Authors:  Bi-Hung Peng; J Ching Lee; Gerald A Campbell
Journal:  J Biol Chem       Date:  2003-09-25       Impact factor: 5.157

9.  Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain.

Authors:  C K Petito; K S Cash
Journal:  Ann Neurol       Date:  1992-11       Impact factor: 10.422

10.  Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions.

Authors:  M Furuse; M Itoh; T Hirase; A Nagafuchi; S Yonemura; S Tsukita; S Tsukita
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

View more
  1 in total

1.  Different effects of ZO-1, ZO-2 and ZO-3 silencing on kidney collecting duct principal cell proliferation and adhesion.

Authors:  Xiaomu Qiao; Isabelle Roth; Eric Féraille; Udo Hasler
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.